Vertex Pharmaceuticals Inc (VRTX)
394.47
+0.99
(+0.25%)
USD |
NASDAQ |
Apr 19, 16:00
393.40
-1.07
(-0.27%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 101.89B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 19, 2024 | 101.89B |
| April 18, 2024 | 101.64B |
| April 17, 2024 | 101.54B |
| April 16, 2024 | 101.82B |
| April 15, 2024 | 102.64B |
| April 12, 2024 | 102.43B |
| April 11, 2024 | 103.38B |
| April 10, 2024 | 102.70B |
| April 09, 2024 | 104.48B |
| April 08, 2024 | 104.41B |
| April 05, 2024 | 105.05B |
| April 04, 2024 | 104.36B |
| April 03, 2024 | 105.60B |
| April 02, 2024 | 105.76B |
| April 01, 2024 | 108.61B |
| March 28, 2024 | 107.98B |
| March 27, 2024 | 107.80B |
| March 26, 2024 | 108.09B |
| March 25, 2024 | 107.46B |
| March 22, 2024 | 107.37B |
| March 21, 2024 | 107.38B |
| March 20, 2024 | 106.45B |
| March 19, 2024 | 107.25B |
| March 18, 2024 | 106.26B |
| March 15, 2024 | 105.31B |
| Date | Value |
|---|---|
| March 14, 2024 | 105.59B |
| March 13, 2024 | 106.73B |
| March 12, 2024 | 106.54B |
| March 11, 2024 | 107.06B |
| March 08, 2024 | 106.83B |
| March 07, 2024 | 106.05B |
| March 06, 2024 | 106.38B |
| March 05, 2024 | 107.31B |
| March 04, 2024 | 109.53B |
| March 01, 2024 | 111.79B |
| February 29, 2024 | 108.68B |
| February 28, 2024 | 110.29B |
| February 27, 2024 | 111.31B |
| February 26, 2024 | 111.97B |
| February 23, 2024 | 111.10B |
| February 22, 2024 | 110.24B |
| February 21, 2024 | 108.39B |
| February 20, 2024 | 108.65B |
| February 16, 2024 | 109.06B |
| February 15, 2024 | 110.11B |
| February 14, 2024 | 107.94B |
| February 13, 2024 | 107.47B |
| February 12, 2024 | 108.11B |
| February 09, 2024 | 109.24B |
| February 08, 2024 | 109.02B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.16B
Minimum
May 13 2019
114.95B
Maximum
Jan 30 2024
68.25B
Average
66.09B
Median
May 01 2020
Market Cap Benchmarks
| Amgen Inc | 144.13B |
| Eli Lilly and Co | 690.55B |
| Regeneron Pharmaceuticals Inc | 98.44B |
| Alpine Immune Sciences Inc | 4.230B |
| Moderna Inc | 38.83B |
Market Cap Related Metrics
| PE Ratio | 28.40 |
| PS Ratio | 10.41 |
| PEG Ratio | 3.437 |
| Price to Book Value | 5.796 |
| Price to Free Cash Flow | 31.34 |
| Price | 394.47 |
| Earnings Yield | 3.52% |
| PEGY Ratio | 3.437 |
| Operating PE Ratio | 23.86 |
| Normalized PE Ratio | 25.72 |